Texas Is About to Reshape Ketamine Therapy — and Clinics Need to Pay Attention
The Texas Medical Board published proposed regulations in January 2026 that will fundamentally change how ketamine clinics operate across the state. Published under Chapter 173, Subchapter B, the rules establish sweeping new standards for what the Board calls Psychotropic Ketamine Therapy (PKT). These proposals carry real consequences — especially for cash-pay clinics that have built their business without the compliance infrastructure these rules now demand.
Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.
| Key Takeaway | What It Means |
|---|---|
| Physician must be onsite during every infusion | Remote or phone oversight no longer qualifies |
| Physicians need documented mental health or ketamine training | General medical education likely will not suffice |
| PKT limited to diagnosed psychiatric conditions | Treating undiagnosed or chronic pain patients becomes noncompliant |
| Clinics must register with the Texas Medical Board | Two year registration with mandatory renewal |
| Detailed patient monitoring standards required | Continuous vitals, O2 saturation, end-tidal CO2, and post-treatment observation |
| Adverse event logs required for three years | Incidents including hospitalization and EMS transport must be documented |
Physician Presence Becomes Mandatory
The most disruptive requirement is straightforward. A physician must be physically present during every ketamine infusion. The proposed rule leaves no room for interpretation. Nurse practitioners and physician assistants can administer treatment, but a physician must remain onsite and immediately available throughout the session. Many Texas clinics currently run with physicians available only by phone. That model ends under these rules.
We identified $23,000+/month in revenue opportunities for practices like yours.
Pricing benchmarks, billing strategies, and a full revenue playbook — built from 23,496 real patient inquiries across 1,473 clinics.
See the Report →Training Requirements Add Another Layer
Physicians ordering PKT must show documented training. The Board requires either formal mental health training or completion of a ketamine specific course for psychiatric use. The rule does not yet specify course length, accreditation standards, or recency requirements. Physicians should begin seeking comprehensive ketamine education now and keep thorough records of completion.
Scope of Treatment Gets Narrowed
The proposed rules restrict PKT to formally diagnosed psychiatric conditions. Treatment resistant depression, PTSD, and suicidal ideation are listed as qualifying indications. Clinics currently treating chronic pain, migraines, or patients with self reported symptoms face the most significant operational shifts. Documented diagnoses will be required before treatment begins.
A Moment to Reconsider the Cash-Pay Model
For clinic owners running entirely on cash pay, these regulations arrive at a pivotal moment. The new compliance costs are real — onsite physician coverage, monitoring equipment, registration fees, and staff training all add overhead. Some owners will absorb those costs. Others will ask whether this is the right time to diversify.
Spravato (esketamine) is worth a serious look. It is the only FDA-approved ketamine-derived treatment for treatment resistant depression and major depressive disorder with active suicidal ideation — two of the exact indications the Texas Medical Board now requires for PKT. Unlike compounded ketamine infusions, Spravato is covered by most major insurance plans and Medicare. That means a clinic already building out the physician presence, monitoring protocols, and diagnostic documentation these new rules require could layer in Spravato without dramatically increasing its compliance burden. The infrastructure overlaps significantly.
The transition is not simple. Spravato carries its own REMS certification requirements, and billing through insurance introduces new administrative complexity. But for a cash-pay clinic in Texas already facing a major operational overhaul, adding an insurance-reimbursed treatment with strong clinical backing may be a more sustainable path forward than absorbing higher costs while keeping the same revenue model.
Compliance Timelines Are Approaching
Legal analysts estimate clinics have roughly six to twelve months to reach full compliance once rules take effect. The Board is currently accepting public comments, and a hearing will follow before final adoption. Some version of these rules is widely expected to pass. Texas clinic operators on the HealingMaps network should audit their current structure now — covering physician availability, physician credentials, patient documentation, monitoring equipment, and consent procedures — and consult a healthcare attorney to close any gaps before the deadline arrives.
Jerron C. Hill MD
March 12, 2026 at 7:50 pmWith respect to the TMB proposed changes regarding IVKI its long overdue. I’m a board certified anesthesiologist. I’ve been practicing anesthesia for thirty six years and opened my ketamine wellness center in 2017. The idea that mid level
healthcare providers have been able to provide IV ketamine infusions while unsupervised is not safe and is not current with ASA guidelines. Anesthesiologist, CRNA’s and ER physicians are the only health care professionals who actually are trained how to use ketamine. How are mid level providers taught how to use IV ketamine and by what standards? Who is supervising and teaching them what my anesthesia attending physicians taught me in residency training? All IV anesthesia induction agents have serious side effects including ketamine. For me it’s all about vigilance and safety. I’ve treated every patient in my clinic since 2017 using ASA guidelines. I’ve done thousands of infusions and have gained significant clinical experience. I’m certain the TMB is justified in its potential rule changes. It’s most likely due to some untoward event that happened to a patient receiving IV ketamine infusion. The TMB implements rules to protect the public. Our priority as healthcare providers must be safety first and not profit. I’d like to see regulation with regard to oral ketamine troches too. The quantity of subscriptions that are written with little to no oversight of physicians without regulation standards is carelessness and may potentially lead to addiction, abuse and misuse. The ASA recommends practitioners having some treatment endpoint in mind when treating patients requiring oral ketamine.